- Home
- PRME vs GF Comparison
PRME vs GF Comparison
Compare PRME & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- GF
- Stock Information
- Founded
- PRME 2019
- GF 1990
- Country
- PRME United States
- GF Germany
- Employees
- PRME N/A
- GF N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- GF Investment Managers
- Sector
- PRME Health Care
- GF Finance
- Exchange
- PRME Nasdaq
- GF Nasdaq
- Market Cap
- PRME 191.7M
- GF 155.4M
- IPO Year
- PRME 2022
- GF N/A
- Fundamental
- Price
- PRME $2.71
- GF $11.97
- Analyst Decision
- PRME Buy
- GF
- Analyst Count
- PRME 6
- GF 0
- Target Price
- PRME $9.38
- GF N/A
- AVG Volume (30 Days)
- PRME 3.3M
- GF 28.1K
- Earning Date
- PRME 08-04-2025
- GF 01-01-0001
- Dividend Yield
- PRME N/A
- GF 0.82%
- EPS Growth
- PRME N/A
- GF N/A
- EPS
- PRME N/A
- GF N/A
- Revenue
- PRME $3,846,000.00
- GF N/A
- Revenue This Year
- PRME $104.12
- GF N/A
- Revenue Next Year
- PRME $196.78
- GF N/A
- P/E Ratio
- PRME N/A
- GF N/A
- Revenue Growth
- PRME 550.76
- GF N/A
- 52 Week Low
- PRME $1.11
- GF $7.38
- 52 Week High
- PRME $6.75
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- PRME 69.76
- GF 64.85
- Support Level
- PRME $1.56
- GF $11.23
- Resistance Level
- PRME $2.78
- GF $11.90
- Average True Range (ATR)
- PRME 0.26
- GF 0.18
- MACD
- PRME 0.08
- GF -0.01
- Stochastic Oscillator
- PRME 76.81
- GF 97.26
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.